Indian Test opener Prithvi Shaw has been suspended by the Board of Control for Cricket in India (BCCI) till November 15, 2019, for a doping violation. According to a BCCI release, Shaw had inadvertently ingested a prohibited substance, which can be commonly found in cough syrups. Mr Shaw had provided a urine sample as part of the BCCI’s anti-doping testing program during the Syed Mushtaq Ali Trophy match on 22nd February 2019 in Indore.
His sample was subsequently tested and found to contain Terbutaline. Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances. On 16th July 2019, Mr Shaw was charged with the commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti-Doping Rules (ADR) and provisionally suspended pending determination of the charge.